The White House is preparing for potential mass firings of federal workers if a government shutdown occurs next week, escalating tensions in a partisan battle over spending plans. Democrats accuse Trump of using intimidation tactics.
The WHO counters claims by the Trump administration linking acetaminophen use during pregnancy to autism, emphasizing no scientific consensus supports this. Experts warn against misinformation.
The Trump administration's recent claims linking acetaminophen use during pregnancy to autism risks have ignited outrage among autism advocates, who argue it perpetuates stigma and guilt for parents. Colin Killick, executive director of the Autistic Self Advocacy Network, voices concerns over the implications of these statements.
As colder months bring respiratory illnesses, a new advisory recommends that you consult a pharmacist before getting your COVID vaccine. No prescription needed, but be prepared for a brief discussion.
The White House has issued a memo warning federal agencies to prepare for mass firings if Congress cannot avert a government shutdown. Tensions rise as Trump cancels meetings with Democrats over budget negotiations.
In a race against time, Bear River Health officials moved swiftly to protect 11 exposed infants from measles, coordinating a vital response that involved notifying families and administering urgent treatments.
Scientists from University College London have made a groundbreaking discovery that could slow the progression of Huntington’s disease. A new gene therapy, AMT-130, shows promising results in clinical trials, potentially changing lives forever.
The Trump administration's recent approval of leucovorin as an autism treatment has sparked outrage among experts, with many calling for more research and caution in prescribing this unproven drug.
Zion Williamson is turning heads at the Pelicans Media Day with a stunning physical transformation. Slimmer and in better shape than ever, he hints at a promising season ahead. Can he stay healthy and dominate on the court?
A groundbreaking partnership aims to provide low-cost lenacapavir to millions at risk of HIV in low- and middle-income countries, potentially transforming HIV prevention efforts worldwide.
